Rainmed Medical Limited (HKG:2297)

Market Cap	399.39M +126.5%
Revenue (ttm)	25.60M -53.0%
Net Income	-113.98M
EPS	-0.10
Shares Out	1.40B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,538,000
Average Volume	946,450
Open	0.2650
Previous Close	0.2650
Day's Range	0.2650 - 0.3150
52-Week Range	0.1280 - 0.5300
Beta	0.67
RSI	63.52
Earnings Date	Mar 27, 2026

About Rainmed Medical

Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2014
• Employees: 214
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2297

Financial Performance

In 2024, Rainmed Medical's revenue was 39.82 million, a decrease of -45.61% compared to the previous year's 73.22 million. Losses were -113.50 million, -2.02% less than in 2023.

Financial numbers in CNY